Spine Firms Make Last-Ditch Appeals For CMS Support Of Percutaneous Lumbar Decompression

Two medical device makers that stand to lose under CMS’ proposed noncoverage of percutaneous image-guided lumbar decompression say the agency’s proposal would unwisely eliminate a promising alternative to invasive surgery for the treatment of lumbar spinal stenosis. One suggests coverage with evidence development to allow more data collection, an approach also advocated by the North American Spine Society.

Vertos Medical Inc. and VertiFlex Inc., two medical device makers that stand to lose under CMS’ proposed noncoverage of percutaneous image-guided lumbar decompression, argue that the proposal would unwisely eliminate a promising alternative to invasive surgery for the treatment of lumbar spinal stenosis.

Their comments, and 195 others, were submitted in response to CMS’ Oct. 17 proposed decision that the minimally invasive procedure...

More from Policy & Regulation

More from Medtech Insight